PIMREG and lung disorder: Although CatS inhibitor treatment in adult βENaC-Tg mice did not lead to reparative or regenerative changes in the lung, early intervention with a CatS inhibitor may have the potential to alter the course of structural lung disease as indicated by data from CatS−/− mouse models [15, 27, 45].